**
The latest report from Cancer Research UK reveals a remarkable decline in cancer death rates in the UK, with figures showing a nearly 30% drop since the 1980s. This positive trend is attributed to advancements in prevention, diagnosis, and treatment. However, despite these improvements, cancer remains the leading cause of death in the country, highlighting the ongoing challenges in the fight against this disease.
A Positive Shift in Statistics
Recent statistics indicate that approximately 247 individuals per 100,000 succumb to cancer annually, a notable decline from the peak of 355 per 100,000 recorded in 1989. This analysis underscores a significant achievement in public health, with cancer mortality rates decreasing by 29% over the past few decades. In the last ten years alone, there has been an 11% reduction in cancer-related deaths, signalling effective interventions.
A closer examination of specific cancers reveals encouraging trends. The death rate for ovarian cancer has plummeted by 19% between 2012-2014 and 2022-2024. Stomach cancer rates have decreased by 34%, while lung cancer deaths fell by 22%. Other cancers, including breast cancer and cervical cancer, also saw reductions of 14% and 11%, respectively. Notably, the mortality rate for oesophageal cancer dropped by 12%.
Areas of Concern
Despite these positive developments, certain cancer types have experienced an uptick in mortality rates. Kidney cancer has risen by 5%, and liver cancer has escalated by 14%. Eye cancer and gallbladder cancer rates have surged even more dramatically, with increases of 26% and 29%, respectively. Moreover, some cancer types, such as thyroid, pancreatic, and melanoma, have maintained stable death rates.
Dr Sam Godfrey, the science engagement lead at Cancer Research UK, emphasised the importance of these statistics, stating, “These figures represent decades of crucial scientific breakthroughs. From vaccines that prevent cancer to kinder, more targeted treatments. Because of this, thousands more people today can make memories, reach milestones and spend precious time with their loved ones.”
The Role of Screening and Treatment Innovations
The report attributes the decline in mortality rates to several key factors, including the implementation of smoking bans and the establishment of screening programmes for breast, bowel, and cervical cancers. Since the initiation of the NHS cervical screening programme, cervical cancer death rates have decreased by an impressive 75%.
The introduction of the human papillomavirus (HPV) vaccine, provided to schoolchildren, has significantly contributed to this decline, with approximately 6.5 million individuals vaccinated since its launch in 2008. Furthermore, advancements in treatments have played a crucial role in reducing prostate cancer deaths, which have decreased by 11% in the last decade, largely due to innovations such as Abiraterone, a drug developed by Cancer Research UK scientists that inhibits testosterone’s role in prostate cancer progression.
Ongoing Challenges in Cancer Care
Despite these encouraging statistics, the increasing and ageing population means that cancer diagnoses are on the rise, with one individual diagnosed every 75 seconds in the UK. Consequently, the total number of cancer-related deaths continues to grow. Alarmingly, a recent analysis revealed that three-quarters of NHS hospital trusts are falling short in their cancer care responsibilities, prompting experts to declare a national emergency.
In response to this crisis, the government recently committed £2 billion to overhaul cancer services, promising patients quicker diagnoses, faster treatment, and enhanced support for living with cancer. However, it is important to note that performance targets set by the NHS have not been met since 2015, with plans to achieve these goals by 2029 under the national cancer strategy.
Why it Matters
The significant drop in cancer death rates in the UK is a testament to the advances made in healthcare over the past few decades, providing hope for thousands of patients and their families. However, the persistent challenges and the rise in certain cancer types underscore the need for continued investment in research, treatment, and support systems. As we celebrate these achievements, it is crucial to remain vigilant and proactive in the fight against cancer, ensuring that every patient receives the care and support they deserve.
